The Pennant Group, Inc. (NASDAQ:PNTG) Short Interest Up 27.5% in March

The Pennant Group, Inc. (NASDAQ:PNTG - Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 331,500 shares, an increase of 27.5% from the February 29th total of 259,900 shares. Currently, 1.2% of the company's stock are short sold. Based on an average trading volume of 134,900 shares, the short-interest ratio is presently 2.5 days.

Analyst Ratings Changes

PNTG has been the subject of several research reports. Oppenheimer boosted their price target on shares of The Pennant Group from $18.00 to $22.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. Truist Financial boosted their price target on shares of The Pennant Group from $16.00 to $21.00 and gave the stock a "hold" rating in a research note on Friday, March 1st. Finally, Stephens upgraded shares of The Pennant Group from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $14.00 to $18.00 in a research note on Friday, January 5th.

The Pennant Group Stock Up 2.4 %

Shares of PNTG stock traded up $0.48 on Monday, reaching $20.11. 319,676 shares of the stock were exchanged, compared to its average volume of 143,261. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.44. The business's 50 day moving average price is $17.33 and its 200 day moving average price is $14.39. The company has a market capitalization of $603.56 million, a price-to-earnings ratio of 45.66, a PEG ratio of 2.11 and a beta of 2.06. The Pennant Group has a twelve month low of $10.31 and a twelve month high of $20.50.

The Pennant Group (NASDAQ:PNTG - Get Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by ($0.01). The Pennant Group had a net margin of 2.46% and a return on equity of 12.78%. The company had revenue of $145.95 million during the quarter, compared to analysts' expectations of $136.79 million. During the same period last year, the firm earned $0.15 earnings per share. As a group, sell-side analysts expect that The Pennant Group will post 0.72 earnings per share for the current fiscal year.

Hedge Funds Weigh In On The Pennant Group

Several large investors have recently bought and sold shares of the stock. Allspring Global Investments Holdings LLC boosted its stake in shares of The Pennant Group by 21.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 5,443 shares of the company's stock worth $61,000 after buying an additional 944 shares during the period. Captrust Financial Advisors boosted its stake in shares of The Pennant Group by 34.8% during the first quarter. Captrust Financial Advisors now owns 4,098 shares of the company's stock worth $76,000 after buying an additional 1,057 shares during the period. Yousif Capital Management LLC raised its holdings in The Pennant Group by 4.6% during the first quarter. Yousif Capital Management LLC now owns 24,711 shares of the company's stock worth $460,000 after purchasing an additional 1,095 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in The Pennant Group by 23.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 6,210 shares of the company's stock worth $68,000 after purchasing an additional 1,162 shares in the last quarter. Finally, UBS Asset Management Americas Inc. increased its holdings in The Pennant Group by 3.9% in the third quarter. UBS Asset Management Americas Inc. now owns 33,699 shares of the company's stock valued at $351,000 after buying an additional 1,264 shares in the last quarter. Institutional investors and hedge funds own 85.88% of the company's stock.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.